Researchers Build Real-World External Control Arm to Accelerate HER2+ Breast Cancer Drug Development – OncLive
Researchers have developed a real-world external control arm to speed up HER2+ breast cancer drug trials, potentially accelerating regulatory approval ...
Read moreDetails